Rainmed Medical Limited announced resignation of Mr. Lau Tsz Ho Tony as an independent non-executive Director with effect from August 15, 2023 due to the need to devote more time for his other commitments. Upon Mr. Lau's resignation as an independent non-executive Director, he has ceased to be a member of the audit committee of the Company with effect from the same date. Mr. Lau has confirmed that he has no disagreement with the Board and there is no matter in relation to his resignation that need to be brought to the attention of the shareholders of the Company or the Stock Exchange.

The Board announced that Mr. Chen Xuefenghas been appointed as an independent non-executive Director and a member of the Audit Committee with effect from August 15, 2023. Mr. Chen Xuefeng, aged 42, obtained a Bachelor of Laws degree from the Southwest University of Political Science and Law in the People's Republic of China (the "PRC") in July 2004. He further received the legal professional qualification certificate in the PRC in February 2007.

Mr. Chen has been certified as a certified public accountant and a certified tax agent in the PRC since December 2015 and June 2011, respectively. Mr. Chen has profound experience in financing and investment. He served as an associate of Guangdong Jundao Law Firm from April 2007 to October 2010 and as a partner of Guangdong Ruiting Law Firm from October 2010 to April 2012, which he gained extensive experience in capital market.

From April to April 2015, he served as a vice president of Shenzhen Jinxin Industrial Group Co. Ltd. Since September 2015, he has been a managing director and person in charge of the investment and financing department of Shenzhen Tiantu Capital Management Center (Limited Partnership), where he is responsible for fund management and project post-investment management. Mr. Chen has confirmed that he has met the independence criteria set out in Rule 3.13 of the Listing Rules.

Save as disclosed above, there is no other matter relating to his appointment as an independent non-executive Director that needs to be brought to the attention of the shareholders of the Company or the Stock Exchange, and there is no other information that need to be disclosed pursuant to any of the requirements under Rule 13.51(2)(h) to 13.51(2)(v) of the Listing Rules.